REGULATORY

• Japan Might Ease Temperature Requirements for Pfizer Vaccine
  February 26, 2021

• MHLW Panel Shelves Decision on Bayer’s Heart Failure Med Vericiguat
  February 26, 2021

• CSL Plans Export of 2 Surplus Human Immunoglobulin Products
  February 26, 2021

• 17,888 Doses of COVID-19 Vaccine Given in Japan as of Feb. 24
  February 25, 2021

• Nichi-Iko Likely to Face Biz Suspension Order over Spate of Recalls
  February 25, 2021

• MHLW Approves Add’l Use for Thaled, Bavencio and More
  February 25, 2021

• 10,000 COVID-19 Patients Received Avigan in Observational Studies: Govt
  February 25, 2021

• MHLW Formally Adopts GS1 Codes for Electronic Package Inserts; Rule to Take Effect August 1
  February 25, 2021

• Japan to Start Elderly Vaccine Rollout from April 12: Minister
  February 25, 2021

• MHLW to Revise Dyslipidemia Drug Development Guideline for 1st Time in 30 Years
  February 25, 2021

• 4 APIs/9 Products Excluded from Kobayashi Kako Biz Suspension for Medical Needs
  February 24, 2021

• MHLW Not Discussing Single-Dose Use of COVID-19 Vaccine: Minister
  February 24, 2021

• Incyte’s Pemigatinib Clears PAFSC, March Approval Likely
  February 24, 2021

• LDP COVID-19 Project Team to Compile Proposal on Single Vaccine Dose
  February 24, 2021

• Orphan Status Granted to Novo’s Concizumab, Eisai’s E7090 and More
  February 24, 2021

• LDP to Set Up Project Team to Strengthen Pharma Sector, Eyes Proposal in May
  February 22, 2021

• Whether to Get COVID-19 Vaccines Up to Individuals to Decide: Govt
  February 22, 2021

• First Possible Adverse Reactions from Pfizer Vaccine Reported in Japan
  February 22, 2021

• Up to 1.17 Million Vaccine Doses to Be Shipped for HCPs in First Half of March
  February 22, 2021

• Govt Plans Ticket Barcode Scan for New Vaccination Tracking System
  February 18, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 157
• 158
• 159
• 160
• 161
• 162
• 163
• 164
• 165
• …
• Next ›
• 最終 »